news-021314-brenner2 (320x240)
Dr. Malcolm Brenner, center, has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.

Renowned cell and gene therapy researcher Dr. Malcolm Brenner, founding director of the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital and Houston Methodist Hospital, has been named a recipient of the Pediatric Blood and Marrow Transplant Consortium’s Lifetime Achievement Award.

As the sixth recipient of the award, Brenner is being recognized for a career that exemplifies the mission of the Consortium “to support research and education to improve the availability, safety, and efficacy of hematopoietic cell transplantation and other cellular therapeutics for children and adolescents.”

Brenner is a professor of medicine, pediatrics – hematology/oncology and molecular and human genetics at Baylor, and in addition to remaining a member of the Center for Cell and Gene Therapy, is a member of the Stem Cell and Regenerative Medicine Center, Texas Children’s Cancer and Hematology Centers, and the NCI-designated Dan L Duncan Cancer Center at Baylor.

Research pioneer

In his over 30-year career, Brenner has led groundbreaking clinical studies and clinical care, trained and mentored fellows and residents, and fostered basic research into pediatric bone marrow transplantation, gene therapy and cellular therapy.

He has pioneered the use of gene transfer in human studies.

Dedication to gene therapy

“His dedication to gene therapy has been instrumental in making strides toward the use of gene transfer to augment the immune response to human tumors, using vaccines and adoptive transfer of genetically modified t-cells,” the Consortium said in announcing his award.

Brenner received his medical and Ph.D. degrees from the University of Cambridge in London, England. He completed fellowships with the Royal College of Pathologists and the Royal College of Physicians.

The Consortium is comprised of more than 100 pediatric bone marrow transplant centers in the United States, Canada, New Zealand, Australia, with affiliate members in Europe, South America and Southeast Asia. They are the largest clinical trials group focused exclusively on blood and marrow transplants for children and adolescents.

Brenner will receive the  award Feb. 27 at the 2014 Tandem BMT Meetings of the American Society for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research to be held in Grapevine, Texas. He will give a special lecture outlining some of his achievements as well as a challenge to the bone marrow transplant community regarding important areas of future research.

Brenner holds the Fayez Sarofim Chair.